| Reference | Sample Size | VTE | PE | DVT | AE | Microvascular thrombosis | Virus |
| Ding YQ et al. [67] | NA | one third of critically ill SARS patients: VTE | NA | NA | NA | NA | SARS-CoV-1 |
| Ren B et al. [63] | 48 | NA | NA | 85.4% | NA | NA | SARS-CoV-2 |
| Zhang L et al. [74] | 143 | NA | NA | 46.1% | NA | NA | SARS-CoV-2 |
| Santoliquido et al. [75] | 84 | NA | NA | 11.9% | NA | NA | SARS-CoV-2 |
| Wichmann D et al. [76] | 12 (death) | 58% | 33% | NA | NA | NA | SARS-CoV-2 |
| Fauvel C et al. [60] | 1240 | NA | 8.3% | NA | NA | NA | SARS-CoV-2 |
| Leonard-Lorant I et al. [77] | 106 | NA | 30% | NA | NA | NA | SARS-CoV-2 |
| Klok FA et al. [64] | 184 | NA | NA | NA | 1.6% | NA | SARS-CoV-2 |
| Marisa D et al. [67] | 10 (death) | NA | NA | NA | NA | 80% | SARS-CoV-2 |